Background Remission and low-disease activity are recommended targets in systemic lupus erythematosus (SLE), yet many ...
Gordian Biotechnology, a biotechnology company focused on discovering and validating therapeutic targets through causal biology, today announced the release of a new preprint, titled: “A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results